BCAL Diagnostics

BCAL Diagnostics FCF per Share

The Free Cash Flow per Share of BCAL Diagnostics (BDX.AX) as of Oct 17, 2026 is -0.02 AUD. In the previous year, Free Cash Flow per Share was -0.02 AUD — a change of -16.45% (higher).

FCF per Share

-0.02AUD

YoY

-16.45%

Last updated:

Free Cash Flow per Share of BCAL Diagnostics is 2025 -0.02 AUD. Free Cash Flow per Share of BCAL Diagnostics was 2024 -0.02 AUD. It decreases by -16.45% higher compared to the previous year.

The BCAL Diagnostics FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
-0.00 AUD
Jan 1, 2019
-0.00 AUD
Jan 1, 2020
-0.00 AUD
Jan 1, 2021
-0.01 AUD
Jan 1, 2022
-0.02 AUD
Jan 1, 2023
-0.03 AUD
Jan 1, 2024
-0.02 AUD
Jan 1, 2025
-0.02 AUD
The BCAL Diagnostics FCF per Share history
YEARFCF per ShareYoY
-0.02AUD-16.45%
-0.02AUD-24.19%
-0.03AUD+91.35%
-0.02AUD+171.52%
-0.01AUD+81.86%
-0.00AUD+24.98%
-0.00AUD+9.84%
-0.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

BCAL Diagnostics Stock analysis

What does BCAL Diagnostics do? BCAL Diagnostics Ltd, based in Sydney, Australia, operates in the Health Care sector within the Biotechnology industry. The company develops innovative blood screening tests for early breast cancer detection, focusing on a lipid biomarker-based approach known as the BCAL test. This technology complements existing imaging methods like mammograms and aims to support screening and monitoring for women of all ages and backgrounds. BCAL Diagnostics has partnered with Precion Inc. to advance clinical trials and regulatory approvals for its diagnostic solutions. BCAL Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BCAL Diagnostics stock

Free Cash Flow per Share of BCAL Diagnostics is -0.02 AUD in 2025.

Free Cash Flow per Share of BCAL Diagnostics changed from -0.02 AUD to -0.02 AUD, representing a -16.45% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share BCAL Diagnostics since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — BCAL Diagnostics

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — BCAL Diagnostics